Amneal Pharmaceuticals to Present at the Barclays Global Healthcare Conference
BRIDGEWATER, N.J., March 6, 2019 /PRNewswire/ -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that members of management will participate in a fireside chat at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel in Miami on Wednesday, March 13, 2019.
To access a live webcast of the presentation, visit Amneal's Investor Relations Web site at https://investors.amneal.com. The webcast can also be accessed at the following URL: https://cc.talkpoint.com/barc002/031219a_as/?entity=98_240D2H3
An archived version will be available approximately one hour after the live presentation and can be accessed at the same location for 90 days.
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has approximately 6,000 employees in its operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States.
Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States, with an expanding portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty division focused principally on central nervous system disorders and parasitic infections. For more information, visit www.amneal.com.
SOURCE Amneal Pharmaceuticals, Inc.